chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fri - 09/13/13 I rec'd vac. around 10 AM at pharmacy - during my hair appt. I had a sore throat. Approx. 1 PM. Back to pharmacy and asked pharmacist why. She said it is possible to have hoarseness, sore throat, etc. Went home 3:15 PM to have a bite to eat. I was going to a wake at 4:30 PM. I couldn't make wake - became disoriented - weak in strength almost blacked out and involuntarily lost control of bladder changed garments and went to bed with my street clothes shoes. Felt somewhat better on Sat. 5 wks later I came down with a bad case of flu some fever - 10-21-22-23 - still some remnants of it cough and a lot of sneezing.
Systemic: Seizure-Mild, Additional Details: patient appeared to have absence seizure x2 with very mild tonic symptoms (head bucked once) - he was unresponsive but quickly snapped out of the "trance" after about 10 seconds - a minute later he repeated the seizure and was out after 5 seconds.  Offered to contact for ambulance to sister (who was with patient) but deemed unnecessary.  Patient had bottle of water and sat for about 30 minutes and was ready to leave.  Contacted patient about 2 hours laters and he said that he felt fine.
Shortness of breath, Dry cough, Very High Blood Pressure, Hospitalize for 4 days. They put me on heart medication-anti-inflammatory pill.
This spontaneous report as received from a healthcare worker via a company representative, refers to multiple (over 40) unspecified patients of unknown age and gender. The concurrent conditions, drug reactions, allergies and medical history of the patients were not reported. On an unknown dates since 06-MAY-2016, the patients were vaccinated with a dose of improperly stored GARDASIL 9, (lot number was L044475 and expiration date of 12-MAY-2017, strength, route of administration and dose were not reported), which was stored on 05-MAY-2016 at -49 Fahrenheit degrees for 15.5 hours, from 06-MAY-2016 to 09-MAY-2016 at -48.7 Fahrenheit degrees for 63.5 hours and on 03-JUN-2016 at -46.9 Fahrenheit degrees for 63.5 hours. The temperature excursions were not detected by a data logger. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of two cases from the same reporter. Additional information has been requested.
No adverse event from vaccination.  Reporting positive COVID-19 test after vaccination with COVID-19 vaccine.
development of Graves hyperthyroidism in the following year, with symptoms having started within a few months of the vaccine
Immediately following both the first and second jabs the injection site was sore which is understandable and within 1-2 days the arm pain was gone.  However, 2.5 weeks after the second jab my injection site has started to hurt and is swollen.  It feels like there is a knot in my shoulder muscle where the injection was, and its very painful.  No visible rash, just pain and minor swelling.  It has not gotten noticeably worse, nor has it gotten any better over the last 4 days.
At routine visit pt was given 1st injection of Hep B vaccine due to history of diabetes. One hour after receiving injection she went to the hospital ED and was admitted to the MICU with nausea, vomiting, epigastric pain, presyncope, hypotension, tachycardia, tachypnea, renal insufficiency, elevated white count. On hospital day #2 she was diagnosed with acute diverticulitis. Will probably be discharged tomorrow.
I received the vaccine on Aug 31 (Tuesday), after dealing with the typical sore arm and tiredness for a few days, I went to work on Friday Sept. 3. Halfway through my shift, I felt very confused (I work in food service) and forgot what I was doing. About a minute later, I felt like I was blacking out and started to fall over. I had to catch myself on the kitchen equipment. I sat in the break room and I was freezing cold, confused and it seemed like my blood pressure was extremely low. (Note: I cook all day long over a 350 degree grill, not once in my 6 years of work have I been cold while at work).  The fatigue and confusion has continued since then and continues to persist. I?m currently in a mental fog, and extremely fatigued as I?m typing this. Each day is different, some days I?m extremely fatigued and confused, other days I?m not as fatigued and confused. However, since the effects began on Sept 3, each day I have felt confused and fatigued- it has not subsided at all. Today it was really bad.
Patient noted circumferential erythema to injection site with pain and warmth locally within first 12 hours. Symptoms worsened despite conservative therapy into cellulitic reaction without abscess formation, fever, chills, or streaking.
hafter 2nd injection bodyaches continued in hip, tehn moved to right hip, bilateral feet and ankles, thighs, shoulders, neck etc and have not subsided, have goteen worse; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 52 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "seasonal asthma," (unspecified if ongoing); "anxiety d/2 COVID" (unspecified if ongoing). Concomitant medication(s) included: WELLBUTRIN XL. Past drug history included: Allergies: lidocaine, reaction(s): "allergies lidocaine". Vaccination history included: Bnt162b2 (Lot number: EK5730, Intramuscular, dose number 1), administration date: 19Dec2020, for COVID-19 immunization, reaction(s): "bodyaches in injection site BUT also in left hip"; Bnt162b2 (Lot number: EK5730, Intramuscular, dose number 1), for COVID-19 immunization, reaction(s): "bodyaches in injection site BUT also in left hip". The following information was reported: PAIN (non-serious), outcome "unknown", described as "hafter 2nd injection bodyaches continued in hip, tehn moved to right hip, bilateral feet and ankles, thighs, shoulders, neck etc and have not subsided, have goteen worse". Therapeutic measures were taken as a result of pain.  Additional information: AE (adverse event) treatment diagnosed with hashimotos disorder and on medication which has not taken away the pain. No COVID prior vaccination. No COVID tested post vaccination. Facility where the most recent COVID-19 vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.
left arm completely numb; tingling; This is a spontaneous report from a contactable other health professional (patient). A 34-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) lot number EL1284 and expiry date unknown, via unspecified route of administration at the left arm on 30Dec2020 12:30 at single dose for Covid-19 immunization in a workplace clinic. Medical history included sinusitis, placenta precreta, infertility, C-section, sulfa allergy, seasonal allergy. The patient's concomitant medications were not reported. The patient previously took hydrocodone, coriander oil; both experienced allergies. The patient had no other vaccine in four weeks. On 31Dec2020 06:00, the patient experienced left arm completely numb and tingling for 4 weeks. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received treatment due to the events. The patient underwent lab tests and procedures which included nasal swab (Covid-19): negative on 26Jan2021. The outcome of the events was recovering.
Red spot a little larger than a quarter at site of injection, hot to touch, painful and itchy.
pt recv vax 10SEP93 & MAR94 pt exp diffuse body pain;MAY94 pt exp reactive arthritis;
Admission 09/29/2021     HPI: This is a 66-year-old male presented to the ED with myalgia, chills, and headache that started today.  Patient has been healthy and denies any sick contacts at home.  Patient had his Covid booster shot 4 days ago (3rd shot).  When patient received his first Covid shot he did not feel any symptoms.  He had 2 Pfizer shots.  His initial shots were in March and April.  Symptoms viewed as moderate. Better with nothing, worse with nothing. No travel overseas.  He reports that he also has chest pain and shortness of breath that was slow onset.  Reports that this morning when he woke up he started having the symptoms.  The knee started gradually but they worsened in the afternoon.  No recent travel no leg swelling.  No nausea no vomiting.  No abdominal pain.  No diarrhea.  No urinary symptoms.  He reports he has very severe myalgias.  Headache is not worst of life.  He did not have any trauma today.  He did not lose consciousness or have any syncopal episode.  There is no neck pain or swelling.  He is chronically paraplegic.
VOMITING; This spontaneous case was received from a healthcare professional on 14-May-2019. It describes a female consumer who experienced vomiting, after the administration of Vivotif for an unknown indication.  Case report: The consumer took the first dose of Vivotif on Saturday. On Monday she had a vomiting.  Action taken with Vivotif was unknown.  The clinical outcome of the event was unknown.  Company's Comment: In this case, it was reported that the consumer experienced vomiting, after the administration of Vivotif. There seems to be a temporal association between the intake of the vaccine and the event. Also, vomiting is labelled as per CCDS. Hence, the causality of the event with Vivotif is assessed as possible.; Sender's Comments: Company's Comment: In this case, it was reported that the consumer experienced vomiting, after the administration of Vivotif. There seems to be a temporal association between the intake of the vaccine and the event. Also, vomiting is labelled as per CCDS. Hence, the causality of the event with Vivotif is assessed as possible.
Rash, UrticariaPruritus, local urticaria of about 3.5 inches at the injection site Narrative:
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients who have received improperly stored doses of PROQUAD (Merck). No adverse effects reported. This is one of several reports received from the same source. Additional information is not expected.
shortness of breath, cough, itching at the library...I was sent to the EMT who ran an EKG, gave me some water, checked vitals...Was recommended to take some benadryl.  Took benadryl mg po within 30 minutes after leaving.  3 days later, I awoke itchy and short of breath with a cough.  I again took benadryl mg po without relief, so 30-45 minutes later ttook another mg benadryl po.
Approx. 11:40 or 11:45 Client passed out while seated in the back of the observation area Client fell to the side but landed face forward and sustained a laceration to the forehead near the hairline on the right side RN called 911 to dispatch EMS around 11:45 After the client passed out a fireman/EMT, physician and nurse were present to arouse the client and assess for further neck or brain injuries RN tended to the bleeding laceration Client gained consciousness and became alert  Client able to answer questions Vaccine Administrator stated that the client mentioned that he was having chest pain but Client denied this and stated that he just felt nervous Client states that he passes out when giving blood and has a needle phobia Nurses and Fireman/EMT assisted client to a wheelchair and back to a private recovery area 11:52 Vitals obtained : O Sat 98, Pulse 56 BP 129/75  Client reports nausea, a flushed sensation, headache and dizziness No Vomiting noted Fireman/EMT took Blood sugar reading with Glucometer. Blood sugar reading is 83  Client reports feeling drowsy but he states that he did not sleep as much as he normally does last night  Fireman/EMT reports Full range of motion to the neck and client reports no neck pain  Ambulance arrives at 12:08 Client previous history was relayed to the paramedics : Vital assessed BP 127/80 and pulsometer in use Paramedic noted that client must have been wearing his sunglasses when he passed out because blood was present on the glasses and the laceration lined up with the sunglasses perfectly  Client discussed what hospital he wanted to be transported to Client does not have a family physician Ambulance left within 10 to 15 minutes after arrival
No additional adverse effects reported.; The caller said the records state that she received her first dose of RECOMBIVAX HB in October 2012 and then her second dose in August 2013 and then no third dose was recorded.; This spontaneous report was received from a consumer of unknown age and gender referring to himself/herself. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On an unknown date in October 2012, the patient was vaccinated with the first dose of hepatitis b vaccine (recombinant) therapy type thimerosal-free (RECOMBIVAX HB) intramuscular injection, lot # J000387, expiration date not reported, but upon internal validation established as 07-SEP-2014, administered intramuscularly for prophylaxis (strength, dose were not provided). On an unknown date in August 2013, she received her second dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection administered intramuscularly for prophylaxis (strength, dose, lot #, expiration date were not provided) (inappropriate schedule of product administration). No third dose was recorded. The patient said she was unsure if she received a third dose. No additional adverse effects or product quality complaint (PQC) were reported.
Information has been received from a lawyer regarding a case in litigation concerning an elderly female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 17-MAR-2010, at age 72, the patient was administered the ZOSTAVAX vaccine by a healthcare provider at a county health department (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a healthcare provider for the following injury resulting from her ZOSTAVAX use: Shingles. The outcome of the shingles is unknown. The patient claimed damages as a result of: injury to herself and economic losses. Additional information has been requested.
The box expiration date looks like 10/14/2024 instead of 10/14/2021. Provider ordered in system with no problem but when looked again in the vial the expiration year was 2021 but not until it was already administered.
Noticed redness and warmth in left thigh DTAP/Hib injection site about 18 to 20 hours after the shot.
Fever with febrile service lasting less than 5 minutes. Seen in ER with normal labs and patient exam normal after post ictal period (<1hr)
I had the shingle shot still got them/Suspected Vaccination Failure; I had shingles about 2 weeks ago.; painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In NOV-2022, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I had the shingle shot still got them/Suspected Vaccination Failure) (serious criteria GSK medically significant), shingles (Verbatim: I had shingles about 2 weeks ago.) and pain (Verbatim: painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-MAR-2023 The case was received from the patient via interactive digital media.  The patient stated he or she had shingles about two weeks ago. The patient had the shot too but still got them. Shingles were very painful. The follow-up could not be possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Injection site flared up; Injection site is knotty; injection site is warm; redness has tripled in size at her deltoid; injection site is very itchy; sore arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE ERYTHEMA (redness has tripled in size at her deltoid) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (redness has tripled in size at her deltoid). At the time of the report, INJECTION SITE ERYTHEMA (redness has tripled in size at her deltoid) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On an unknown date, She had a tuberculosis test done before the swelling happened. On 12-JAN-2021, she got a purified protein derivative test on the same arm but at her forearm. Concomitant medications were not provided. Treatment medication included anti-allergy medication.
muscle pain in the leg and arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Apr-2021 and was forwarded to Moderna on 16-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain in the leg and arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain in the leg and arm). At the time of the report, MYALGIA (muscle pain in the leg and arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Dizzy, lightheaded, faint within 15 minutes for 1 hour. Chills, fever, body aches for 3 days. Extreme exhaustion, weakness, and soreness for one week. Exhaustion, weakness, and soreness limiting normal abilities for nearly 2 months.
Extremely prominent veins on upper chest on left side after covid vaccine. Haven't gone away at all since then. Got an ultrasound to check for blood clots. No blood clots but veins are still very odd.
On the evening of 3/6/2023, I developed a sore throat, which was followed by a severe cough, runny nose, and light headache. Over the following week, I had the same symptoms, but the headaches were worse. I was also easily fatigued. I took a home antigen 3/9/2023 and got a positive result. I then saw my doctor, who prescribed me Paxlovid, which I began that evening. The symptoms stayed pretty much the same until two or three days afterwards. They then lessened. I still had the cough, runny nose, headache, and fatigue, but they were less intense. I took a home antigen test earlier today and got a negative result, but I still have the symptoms of coughing, runny nose, light headache, and fatigue. The advisory on the box indicated that the test shouldn't be used after July 2022, but I don't know if that makes a difference.
my body physically shut  down on me. i got uncomfortably cold and picked up a cough that i could not get rid of. i am still coughing aggressively today which is 5 months later.
Pt called Monday 12/7/15 re below. Received MMR on 12/4/15 noon and pt went to work and on the evening pt developed increased pain on both legs and unable to walk and continue on Saturday; Sunday AM leg pain decreased but developed pain on both arms and chest discomfort and dry cough, no rashes, no fever. Instr to go to ER for further evaluation. No egg allergy.
Patient presented at day (+) 13 from vaccinia vaccination with 1-2 mm erythematous based macular papular lesions over his neck, chest, lower abdomen, and back. The total number of the lesions were probably in the order of 8-10. A sample of one of the lesions was sent for vaccinia PCR (on protocol at Military Medical Center). The patient had no other symptoms (he saw the lesions but never felt them due to symptoms). These lesions are c/w a fair number of reactions that are preliminarily being referred to as post-vaccinial non-viral pustulosis. The patient has recovered completely. His vaccination site was a mature jennernian pustule.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION (GOT VIRUS); This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) start therapy date and end date were not reported, 1 total frequency dose was administered for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced suspected clinical vaccination failure, and suspected covid-19 infection (got virus). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure and suspected covid-19 infection (got virus) was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000182759.; Sender's Comments: V0: 20210627140-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
General soreness of right arm, like a moderate bruise.    I just wanted you to have a non-severe reaction for your records.  I ate supper with no problem.  I ate lunch with no problem.  NO illness of any kind.
Information has been received from a physician concerning the daughter of a nurse who was vaccinated with a first dose of Gardasil. Patient experienced "nausea" within 24 hours after she received the first dose of Gardasil. It was not known if the patient sought medical attention. The patient's outcome was unknown. The physician reported that two other patient experienced nausea after receiving Gardasil. Additional information has been requested.
Chills fever over 100 for almost 24 hours muscle and joint pain severe headache
This spontaneous report as received from a pharmacist refers to three patients of unknown age were inadvertently administered ZOSTAVAX single dose (lot # 0364AE, expiry date on 16-MAR-2013). Two patients were administered the expired ZOSTAVAX on 30-APR-2013 (MARRS# 1305USA0046421) and one patient was administered the expired ZOSTAVAX on 07-MAY-2013. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.